MAIA Biotechnology
Dr. Adam Yopp is the Occidental Chemical Chair of Cancer Research and an Associate Professor and Division Chief of Surgical Oncology and Colorectal Surgery, at Harold C. Simmons NCI-designated Comprehensive Cancer Center at UT Southwestern Medical Center in Dallas. Dr. Yopp completed a fellowship in surgical oncology at Memorial Sloan-Kettering Cancer Center focusing on upper GI and hepatopancreatobiliary malignancy and joined UT Southwestern in 2009. At UT Southwestern, Dr. Yopp is the Director of the Liver Tumor Program and both his research and clinical interests are focused on the delivery of care in patients with primary liver cancer. Specifically, he has NIH and DOD funding examining the racial and ethnic disparities in outcome measures for patients newly diagnosed with hepatocellular carcinoma. In addition, as the Director of the UT Southwestern Biorepository he is focused on translational collaborations expanding our genomic characterizations of upper GI and hepatopancreatobiliary malignancies.
This person is not in the org chart
This person is not in any offices
MAIA Biotechnology
2 followers
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.